Clinical Trial Update: Luteolin for the Treatment of People With Schizophrenia [NA]

View source ↗

Summary

Sponsored by the University of Maryland, Baltimore, a clinical trial evaluating luteolin for schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Luteolin (luteolin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED